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Abstract
We summarize the 2015 International Conference on Intelligent Biology and Medicine (ICIBM 2015) and the editorial
report of the supplement to BMC Genomics. The supplement includes 20 research articles selected from the manuscripts
submitted to ICIBM 2015. The conference was held on November 13–15, 2015 at Indianapolis, Indiana, USA. It included
eight scientific sessions, three tutorials, four keynote presentations, three highlight talks, and a poster session that covered
current research in bioinformatics, systems biology, computational biology, biotechnologies, and computational medicine.
Introduction
The 2015 International Conference on Intelligent Biology
and Medicine (ICIBM 2015) brought together more than
one hundred twenty researchers and trainees from multiple
countries with highly interdisciplinary background such as
biology, medicine, computer science, biomedical engineer-
ing, statistics, mathematics, and chemistry, among others,
participated this exciting three-day event. The event pro-
vided a forum for attendees to exchange new ideas, dem-
onstrate new tools, showcase recent innovative work, and
foster interdisciplinary research collaborations. It was also
an important educational and training venue for students
and junior investigators in bioinformatics, systems biology,
intelligent computing, and computational medicine.
The scientific program included eight scientific sessions
covering seven important areas, four tutorials, four key-
note presentations, nine highlight talks, and a poster ses-
sion. Among the scientific sessions, since there are many
interesting and important work related to the area of next
generation sequencing data analysis, it was split into two
sessions held on different days. The detailed information
of all presentations and posters can be found on the con-
ference website [1] and in the conference program book.
Here we briefly review the keynote speakers’ presentation,
followed by the tutorials, and the papers selected by BMC
Genomics in the regular scientific sessions.
Keynote lectures
Four keynote speakers who are world-renowned leaders
in bioinformatics, medical informatics, integrative gen-
omics, systems biology and computational medicine
delivered lectures on their cutting-edge research, pro-
vided insightful views for their research fields, and
shared their perspectives on the future of these fields in
the era of big data. These speakers were Dr. Jiajie Zhang
from The University of Texas Health Science Center at
Houston, Dr. Christopher Sanders from Harvard Med-
ical School, Dr. Keith Dunker from Indiana University,
and Dr. Sylvia Plevritis from Stanford University. Below,
we briefly introduce the four keynote presentations.
“Beyond Big Data: New Trends in Biomedical Informat-
ics Research and Education” by Dr. Jiajie Zhang. Dr.
Zhang is the Dean, the Glassell Family Foundation Distin-
guished Chair in Informatics Excellence, and the Dr. Doris
L. Ross Professor at The University of Texas School of
Biomedical Informatics. He is an elected fellow of the
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American College of Medical Informatics. Dr. Zhang in
his presentation provided insights on the rapidly emerging
new trends in biomedical informatics beyond the current
Big Data Revolution. He pointed out that Big Data itself
cannot solve any problems, instead what the community
needs are precise, small scale, transparent, live knowledge
and intelligence for the right problem of a right individual
at the right time and the right location, with the power of
prediction and intervention. In addition, Dr. Zhang dis-
cussed these new trends in biomedical informatics re-
search and education as the promise of data in medicine
and biology will not be realized without a new generation
of students, researchers, and developers who are trained
with the state-of-the-art tools and equipped with the most
up-to-date knowledge in biomedical informatics.
“Systems Biology in Action: Prediction of Large Protein
3D Structures and Design of Cancer Combination Ther-
apy” by Dr. Christopher Sander. Dr. Sander was Head of
the Computational Biology Center at Memorial Sloan
Kettering Cancer Center and Tri-Institutional Professor
at Rockefeller and Cornell Universities. Dr. Sander is a
pioneer and world leader in computational biology. In
this presentation, he presented his recent high impact
work on systems pharmacology, computational genom-
ics, and protein structure and function. First, he intro-
duced perturbation biology, a method for computing
responses to combinatorial therapy aiming to block the
emergence of resistance to targeted cancer therapies. In
addition, he presented cBioPortal for cancer genomics in
collaboration with Niki Schultz and Ethan Cerami being
information resource architects under his leadership. Fi-
nally, he showed recent work on solving the 3D protein
folding prediction problem using statistical physics and
information from next-generation sequencing in collab-
oration with Debora Marks at Harvard Medical School
and the Zecchina group at the Politecnico di Torino.
“Intrinsically Disordered Protein and the Origins of Com-
plex Multicellular Organisms” by Dr. Keith Dunker. Dr.
Dunker is a renowned protein scientist and a professor of
Biochemistry and Molecular Biology and was the Director
of the Center for Computational Biology and Bioinformat-
ics at Indiana University. In this presentation, Dr. Dunker
focused on understanding two important biological ques-
tions for evolution of multicellular organisms: First, which
molecular functions underpinned the evolution of multi-
cellular organisms? Secondly, which of these molecular
functions depend on the intrinsically disordered proteins
(IDP)? Answers to the first question involve the advent of
molecules for cellular adhesion, cell-cell communication,
developmental programs, spatial and temporal regulation
of the developmental programs as well as cell-specific bio-
chemistry. For the second question, Dr. Dunker and his
colleagues used key-words in Swiss Protein ranked for
associations with predictions of protein structure or
disorder and found that “differentiation” was the biological
process most strongly associated with IDPs. In addition, all
of the aforementioned five underpinning molecular func-
tions for multicellularity were found to strongly depend on
IDP-based mechanisms. These findings lead to new direc-
tion in characterizing the evolution of complex multicellu-
lar organisms and using gene regulatory network models
currently used to explain cellular differentiation.
“Optimizing Combination Cancer Therapy Based on
Single Cell Analysis” Presented by Dr. Sylvia Plevritis.
Dr. Plevritis is a Professor of Radiology in the School of
Medicine and (by courtesy) of Management Science and
Engineering in the School of Engineering at Stanford
University. She is co-Section Chief of Integrative Bio-
medical Imaging Informatics (IBIIS) at Stanford Univer-
sity, Director of the Stanford Center for Cancer Systems
Biology (CCSB) and Director of the Cancer Systems
Biology Scholars (CSBS) postdoctoral training program.
Tumors often evolve under exposure to different treat-
ment regimes, leading to intratumor heterogeneity and
different clinical outcomes. Personalized treatment strat-
egies are thus required to improve the effectiveness of
cancer drug combination therapy. In this study, Dr. Plevritis
and her colleagues aim to identify optimal cancer drug
combinations based on characterization of an individual pa-
tient’s intratumoral heterogeneity in response to a screening
panel of single drugs at the single cell level. Specifically, Dr.
Plevritis presented mass cytometry, the state-of-the-art sin-
gle cell technology, to elucidate the intratumoral response
to drug exposure. This approach is based on a set of novel
algorithms to analyze the high- dimensional data generated
by the mass cytometry. The ultimate goal of this study is to
optimize cancer drug combinations for each patient by cap-
turing an individual patient’s intratumoral heterogeneity
through integrative single-cell based analyses based on
proteomic, genomic and imaging data.
Tutorials
ICIBM 2015 included three tutorial sessions covering
frontier and emerging research topics such as next-
generation sequencing data analysis, proteomics, and bio-
image informatics. These tutorials were well attended and
appreciated by the conference participants. They provided
a wealth of information on these cutting-edge areas and
techniques in bioinformatics and computational biology.
“Advanced Data Mining and Quality Control of High
Throughput Sequencing Data” (provided by Dr. Yan Guo
from Vanderbilt University): Illumina high throughput
sequencing (HTS) technology is one of the most preva-
lent high throughput sequencing technologies driving
genomic studies. However HTS data creates numerous
bioinformatics challenges due to its complexity, yet sim-
ultaneously offer exciting new opportunities for mining
new biomedical informatics from the vast amount of
The Author(s) BMC Genomics 2016, 17(Suppl 7):524 Page 80 of 325
data. In this tutorial, Dr. Guo discussed two major as-
pects of HTS data analysis: quality control (QC) and
data mining. QC is critical for downstream analysis but
a common myth is that quality control is only needed at
the raw data. In fact, QC for HTS data needs to be
carried out in at least three stages: raw data, alignment,
and variant calling. In this tutorial, Dr. Guo introduced
the concept of multi-perspective QC and discussed the
detailed QC strategies for both RNA and DNA sequen-
cing data. HTS data with proper QC also provide unique
opportunities for data mining, and the specific type of
data mining depends on the specific sequencing
methods. Dr. Guo specifically introduced potential min-
able components from both exome and RNA-seq data
and discussed the appropriate approach for each of the
components.
“Novel genotype-phenotype associations in human can-
cers enabled by advanced molecular platforms and com-
putational analysis of whole slide images” This tutorial
was organized by Dr. Lee Cooper from Emory University
and Dr. Kun Huang from the Ohio State University. Ad-
vances in computing, imaging, and genomics have cre-
ated new opportunities for exploring relationships
between histology, molecular events, and clinical out-
comes using quantitative methods. Slide scanning de-
vices are now capable of rapidly producing massive
digital image archives that capture histological details in
high resolution. Commensurate advances in computing
and image analysis algorithms enable mining of archives
to extract descriptions of histology, ranging from basic
human annotations to automatic and precisely quantita-
tive morphometric characterization of hundreds of mil-
lions of cells. These imaging capabilities represent a new
dimension in tissue-based studies, and when combined
with genomic and clinical endpoints, can be used to ex-
plore biologic characteristics of the tumor microenviron-
ment and to discover new morphologic biomarkers of
genetic alterations and patient outcomes. In this tutorial,
Drs. Cooper and Huang described recent developments in
quantitative pathology imaging and illustrate how image
features can be integrated with clinical and genomic data
to investigate fundamental problems in cancer. Using mo-
tivating examples from the study of gliomas (GBMs), Dr.
Cooper also demonstrated how public data from The
Cancer Genome Atlas (TCGA) can serve as an open plat-
form to conduct in silico tissue-based studies that inte-
grate existing data resources.
“Computational Challenges in Top-Down Proteomics”
This tutorial is offered by Dr. Xiaowen Chen from
School of Informatics and Computing at IUPUI. While
the genome provides the blueprint of gene products,
proteins are the bricks and mortar of biology. Mass
spectrometry (MS) is the core technology for the studies
of proteins and post-translational modifications. Over
the past decade, proteomics has been dominated by
bottom-up MS that digests proteins into fragments and
analyzes the resulting short peptides. Since information
about intact proteins is lost during digestion, recent
studies advocated top-down MS that analyzes intact pro-
teins and gives rise to many computational challenges.
While top-down MS researchers have made great pro-
gress, the algorithms for interpreting top-down MS data
are still in their infancy. We describe computational
challenges and combinatorial algorithms for the analysis
of top-down MS data and show how they enable new
biological applications.
Scientific sessions and BMC Genomics / Systems Biology
supplement issues
ICIBM 2015 had eight regular scientific sessions cover-
ing recent research in the areas of bioinformatics, sys-
tems biology, intelligent computing, and computational
medicine. The detailed information of the sessions, in-
cluding session chairs, authors, presenters, and the title
and abstract of each talk were made available on the
conference website [1] and in the conference program
brochure. The presentations were selected through a
rigorous review process from more than 60 submissions
based on their scientific merit and technical quality by a
program committee of more than 90 experts in the field
(see the Conference Organization section below). These
sessions were:
Session I: NGS Data Analysis, I
Session II: Systems Biology
Session III: NGS Data Analysis, II
Session IV: Integrative Genomics
Session V: Genomics and Genetics
Session VI: Epigenomics, Proteomics and Metabolomics
Session VII: Biomarker Discovery and Precision Medicine
Session VIII: Pharmacogenomics and Systems Medicine
Here we present the editorial report for the supplement
to BMC Genomics that includes 20 research papers. Each
selected manuscript was reviewed for two rounds. The first
round of reviewed was carried out by at least three
reviewers and was substantially revised according to re-
viewers’ critiques. The revision was further reviewed by at
least two reviewers before being accepted into the supple-
ment issue. These papers cover a wide spectrum of topics
in bioinformatics and computational biology. Below we
group the papers in this special issue of BMC Genomics
into five categories and summarize them.
Next and the third generation sequencing data analysis
methods
While next generation sequencing (NGS) techniques
have been widely adopted by biomedical community
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during the past decade, new experimental techniques
and even the third-generation sequencing technology
keep proposing new challenges for data analysis. During
the conference, several groups proposed new methods
or methods comparison for processing and analyzing
NGS and third generation sequencing data. In [2], Feng
et al. proposed a Bayesian inference-based method that
takes advantage of the signal distributions of electrical
voltages measured for all the homopolymers for third
generation sequencing technology such as the Nanopore
sequencer. By cross-referencing the length of homopoly-
mers in the reference genome and the voltage signal dis-
tributions, the proposed integrated model significantly
improves the alignment accuracy around the homopoly-
mer regions. Cherukuri and Janga [3] then benchmarked
available assembler algorithms such as de Bruijn graphs,
Overlap Layout Consensus (OLC) and Greedy extension
approaches to find an appropriate framework that can
efficiently assemble Nanopore sequenced reads. Their
analysis unveiled that OLC-based algorithms could gen-
erate a high quality assembly with ten times higher N50
& mean contig values as well as one-fifth the number of
total number of contigs compared to other tools. The
findings should help in stimulating the development of
novel assemblers for handling Nanopore sequence data.
In [4], the study aimed to evaluate the appropriateness
of different statistical distributions on modeling
sequence-context-dependent DNA sequencing error
rates generated by different NGS technologies. Using a
generalized linear model framework, Hao et al. found
that zero-inflated negative binomial distribution fits the
sequencing errors the best and also performed the best
in identifying low-frequency single nucleotide variants
(SNVs), especially within the 0.5 % to 1 % ranges in two
commonly used sequencing platforms with completely
different biochemistries - Ion Proton and Illumina
MiSeq. This work provides guidance in predicting se-
quencing errors and facilitates low-frequency SNV de-
tection as well as their downstream applications. The
development of single-cell RNA sequencing enables
tracking cell heterogeneity and determination of cell
subpopulations. Chen et al. [5] developed a gene expres-
sion variation model (GEVM), utilizing the relation be-
tween coefficient of variation (CV) and average
expression level to address the over-dispersion of single-
cell data, and its corresponding statistical significance to
quantify the variably expressed genes (VEGs). Obtaining
VEGs allowed researchers to detect possible subpopula-
tions, providing further evidences of cell heterogeneity.
In Cui et al. [6], the authors developed a novel algorithm
for uncovering the potential types of m6A methylation
by clustering the degree of m6A methylation peaks in
MeRIP-Seq data. This algorithm utilizes a hierarchical
graphical model to model the reads account variance
and the underlying clusters of the methylation peaks. It
was applied to two different MeRIP-seq datasets and re-
vealed a novel pattern that methylation peaks with less
peak enrichment tend to clustered in the 5’ end of both
in both mRNAs and lncRNAs, whereas those with
higher peak enrichment are more likely to be distributed
in CDS and towards the 3’end of mRNAs and lncRNAs.
These results suggest that m6A’s functions could be lo-
cation specific.
Applications of sequence and NGS data analysis methods
In addition to developing novel methods for analyzing
data generated from new NGS techniques or the third-
generation technology, application of NGS technologies
to biological and medical problems also calls for exten-
sive bioinformatics research. Bai et al. [7] has investi-
gated the variation of gene expression in blood
transcriptome profile of Chinese Holstein cows associ-
ated to the milk yield traits. Totally, 100 differentially
expressed genes (DEGs) between 13 high yielders and 10
low yielders were obtained, which were shown to be sig-
nificantly enriched in immune response processes. Fur-
thermore, alternative splicing analysis demonstrated that
the alternative 3’ splicing site was the major splicing pat-
tern in high yielders, however, in low yielders was exon
skipping. This study allowed us to explore associations
between immune traits and production traits related to
milk production. In [8], Zhou et al. identified 197 exons
whose BMSC splicing patterns were altered by LPS via
comparing RNA-seq data from LPS-treated samples ver-
sus the control. Functional analysis of these alternatively
spliced genes demonstrated significant enrichment of
phosphoproteins, zinc finger proteins, and proteins
undergoing acetylation. Additional bioinformatics ana-
lysis strongly suggest that LPS-induced alternatively
spliced exons could have major effects on protein func-
tions by disrupting key protein functional domains,
protein-protein interactions, and post-translational mod-
ifications. The study provides greater understanding of
the intracellular mechanisms that underlie the thera-
peutic potential of BMSCs. The evolution of exception-
ally powerful transporter systems in Streptomyces has
enabled their adaptation to the complex soil environ-
ment. A better understanding of transport systems will
allow enhanced optimization of production processes for
both pharmaceutical and industrial applications of Strep-
tomyces. In [9], Zhou et al. presented a catalog of trans-
port systems in eleven Streptomyces species and found
that each of the species possesses a rich repertoire of
transport proteins, which can be divided into a wide
range of transporter families. To characterize the bio-
logical and medical significance of Bacillus sp. NRRL B-
14911, in particular, cardiac autoimmunity, Massilamany
et al. [10] sought to analyze the complete genome
The Author(s) BMC Genomics 2016, 17(Suppl 7):524 Page 82 of 325
sequence of this bacterium. The genome was found to
encode several virulence factors like adhesins, invasins,
colonization factors, siderophores and transporters. The
availability of complete genome sequence of this bacter-
ium may facilitate genetic manipulations to assess gene
functions associated with bacterial survival and viru-
lence, and also to establish a disease model to study the
immune pathogenesis of bacterial myocarditis. In [11],
Bai et al. presented an improved algorithm “Read-Split-
Run” (RSR) for detecting genome-wide Ire1α-targeted
genes with non-canonical spliced regions at a faster
speed. They compared the RSR algorithm to the “Read-
Split-Walk” (RSW) algorithm when applied to mouse
embryonic fibroblast cells (MEF) and the human
Encyclopedia of DNA Elements (ENCODE) RNA-seq
data. The new RSR algorithm outperformed others in
the defined context and showed a higher efficiency in
identifying novel splice junctions genome-wide.
Integrative genomics and precision medicine
One important issue in precision medicine is how to
effectively integrate multiple modalities of biomedical
data, especially different sets of high throughput
molecular data to better stratify patients into groups
with distinctive clinical outcomes such as different prog-
nosis and response to treatment. During this conference,
a series of papers proposed different integrative genomic
methods to achieve this goal. While whole exome-
sequencing is widely used to screen for somatic muta-
tions in cancer patients, the mutations often do not
occur on the same genes among patients. In [12], Zhang
et al. developed a novel approach of integrating patient
somatic mutation, transcriptome and clinical data to
mine underlying functional gene groups that can be used
to stratify cancer patients into groups with different clin-
ical outcomes. Specifically, distance correlation metric
was used to mine the correlations between expression
profiles of mutated genes from different patients. With
this method, a stable subgroup of breast cancer patients
that are highly enriched with ER-negative and triple-
negative subtypes were identified, and the somatic muta-
tion genes they harbor were capable of acting as poten-
tial biomarkers to predict patient survival in several
different breast cancer datasets, especially in ER-negative
cohorts which has lacked of reliable biomarkers. The
method provides a novel and promising approach of in-
tegrating genotype and gene expression data in patient
stratification in complex diseases. Proper cell models for
breast cancer primary tumors have long been the focal
point in the cancer’s research. In [13], a comprehensive
comparison in copy number variation (CNV), mutation,
mRNA expression and protein expression between 68
breast cancer cell lines and 1375 primary breast tumors
is conducted and presented. The important drug targets,
ESR1, PGR, HER2, EGFR and AR have a high similarity
in mRNA and protein in both tumors and cell lines. A
total score developed from the four correlations among
four molecular profiles suggests that cell lines, BT483,
T47D and MDAMB453 have the highest similarity with
tumors. In [14], Wang et al. proposed an integrative gen-
omics approach to explore the functional consequences
of a key driver gene, PBRM1 through its truncated mu-
tations in clear cell renal cell carcinoma (ccRCC) by in-
corporating somatic mutations, mRNA expression, DNA
methylation, and microRNA expression profiles from
The Cancer Genome Atlas (TCGA). Their results sug-
gested that methylation and microRNA alterations were
likely the downstream events associated with the PBRM1
truncation mutations. This study provided some import-
ant insights into the understanding of tumorigenesis
driven by PBRM1 truncated mutations in ccRCC.
Cancer biomarker discovery and pan cancer study
Discovery of biomarkers and signatures is an important
issue in translational research for cancers. During this con-
ference, several studies focused on the methods for identify-
ing cancer specific or common signatures and markers
predicting clinical outcomes for cancer patients. For in-
stance, to classify cancer classes (e.g. subtypes) using patient
gene expression profiles when both systematic and
condition-specific biases presented, Ma et al. [15] developed
a novel algorithm called CrossLink (CL). CL exploits the
fact that the signature is unique to its associated class under
any condition and thus employs an unsupervised clustering
algorithm to discover this unique signature. The results
showed that CL can achieve robust and improved perform-
ance than state-of-the-art normalization algorithms. In
[16], the authors performed a pan-cancer analysis of copy
number of variants (CNVs) and gene expression in one of
the most important gene categories, tumor suppressor
genes (TSGs), in order to provide a systematic view of
CNV and gene expression concordant changes in TSGs
across all the major cancers. They found that 81 TSGs with
concordant copy number loss events and decreased gene
expression in the tumor samples and provided a draft land-
scape of CNV in pan-cancer. In [17], Zhang and Chen pre-
sented a peptidomics method for identifying cancer-related
and isoform-specific peptide for clinical proteomics applica-
tion from LC-MS/MS. They showed that the method for
identifying cancer-specific protein isoform biomarkers from
clinical proteomics application is an effective one for in-
creasing the number of identified alternative splicing iso-
form markers in clinical proteomics.
Translational bioinformatics and pharmacogenomics
Translational bioinformatics methods including network
analysis are widely applied to human disease studies and
pharmacogenomics applications. In [18], Chen et al.
The Author(s) BMC Genomics 2016, 17(Suppl 7):524 Page 83 of 325
developed a drug repositioning approach combining
human disease genomics and mouse phenotype data
towards predicting targeted therapies for glioblastoma
(GBM). For existing GBM drugs, this approach achieved
a significantly higher median rank than a recent ap-
proach (9.2 % vs. 45.6 %). In addition, many top predic-
tions have been demonstrated effective in inhibiting the
growth of human GBM cells. In [19], Li et al. extracted
the functional modules and identified 19 key rifampin-
response genes that are associated with seven function
pathways that include drug response and metabolism,
and cancer pathways. In addition, six genes functioning
as gene hubs in the gene networks that are regulated by
rifampin was identified. The results suggest that rifam-
pin contributes to changes in the expression of genes by
regulating key molecules in the protein interaction net-
works. In [20], Xu and Wang presented an integrated
approach for drug repurposing for rheumatoid arthritis
(RA). They developed a network-based ranking algo-
rithm to find diseases that shared high degrees of genetic
commonality with RA and then implemented a drug
prioritization algorithm to reposition drugs from RA-
related diseases to treat RA. This approach performed
significantly better in novel predictions than the existing
approach when evaluated using 165 not-yet-FDA-ap-
proved RA drugs. While gene co-expression network
analysis is widely adopted, there is a lack of a rigorous
way to evaluate the concordance of the expression pro-
files for the genes in co-expressed modules. Han et al.
[21] presented a linear algebraic based Centralized Con-
cordance Index (CCI) for evaluating the concordance of
co-expressed gene modules from gene co-expression
network analysis. The CCI can be used to evaluate the
performance for co-expression network analysis algo-
rithms as well as for detecting condition specific co-
expression modules.
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